Leveraging Stem
Cells for Drug
Delivery
HemaCure, Inc. develops cell-based
therapeutics for diseases with
significant medical unmet need and
commercial potential.
Parkinson's
Disease
Alzheimer's
Disease
Blood and Immune
Rejuvenation
Rare Disease
Targets
Leveraging Stem
Cells for Drug
Delivery
HemaCure, Inc. develops cell-based
therapeutics for diseases with
significant medical unmet need and
commercial potential.
Parkinson's
Disease
Alzheimer's
Disease
Blood and Immune
Rejuvenation
Rare Disease
Targets
Leveraging Stem
Cells for Drug
Delivery
HemaCure, Inc. develops cell-based
therapeutics for diseases with
significant medical unmet need and
commercial potential.
Parkinson's
Disease
Alzheimer's
Disease
Blood and Immune
Rejuvenation
Rare Disease
Targets
Leveraging Stem
Cells for Drug
Delivery
HemaCure, Inc. develops cell-based
therapeutics for diseases with
significant medical unmet need and
commercial potential.
Parkinson's
Disease
Alzheimer's
Disease
Blood and Immune
Rejuvenation
Rare Disease
Targets

About Us

About Us

Learn more about HemaCure and our biotech industry and academic veterans.

Pipeline

Pipeline

Status of our clinical and pre-clinical pipeline, including our Parkinson's Disease and rare disease programs.

Our Focus: CD34+ Cell Replacement

Our Focus: CD34+ Cell Replacement

Learn more about HemaCure's bone marrow replacement and cell engineering technologies.

News

News

The latest news about HemaCure, including milestones and press releases.

Corporate Presentation

Corperate Presentation

Full listing of HemaCure's corporate presentations.

© 2020 HemaCure, inc. All rights reserved.